119 related articles for article (PubMed ID: 9210979)
1. Percutaneous absorption and disposition studies of methotrexate in rabbits and rats.
Lu G; Jun HW; Suh H
Biopharm Drug Dispos; 1997 Jul; 18(5):409-22. PubMed ID: 9210979
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs.
Lu GW; Jun HW; Dzimianski MT; Qiu HC; McCall JW
Pharm Res; 1995 Oct; 12(10):1474-7. PubMed ID: 8584484
[TBL] [Abstract][Full Text] [Related]
3. Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.
Qian M; West W; Wu JT; Lu B; Christ DD
Pharm Res; 2003 Apr; 20(4):605-10. PubMed ID: 12739768
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats.
Suh H; Jun HW; Dzimianski MT; Lu GW
Biopharm Drug Dispos; 1997 Oct; 18(7):623-33. PubMed ID: 9330782
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of topical delivery of methotrexate by electroporation.
Wong TW; Zhao YL; Sen A; Hui SW
Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
[TBL] [Abstract][Full Text] [Related]
7. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
Yuan SH; Ge WH; Huo J; Wang XH
Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous permeation of N,N-diethyl-m-toluamide (DEET) from commercial mosquito repellents and the effect of solvent.
Stinecipher J; Shah J
J Toxicol Environ Health; 1997 Oct; 52(2):119-35. PubMed ID: 9310145
[TBL] [Abstract][Full Text] [Related]
9. Inverse targeting of peritoneal tumors: selective alteration of the disposition of methotrexate through the use of anti-methotrexate antibodies and antibody fragments.
Balthasar JP; Fung HL
J Pharm Sci; 1996 Oct; 85(10):1035-43. PubMed ID: 8897267
[TBL] [Abstract][Full Text] [Related]
10. Effect of ketoprofen and indomethacin on methotrexate pharmacokinetics in mice plasma and tumor tissues.
Elmorsi YM; El-Haggar SM; Ibrahim OM; Mabrouk MM
Eur J Drug Metab Pharmacokinet; 2013 Mar; 38(1):27-32. PubMed ID: 23161397
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of insect repellent N,N-diethyl-m-toluamide in beagle dogs following intravenous and topical routes of administration.
Qiu H; Jun HW; Tao J
J Pharm Sci; 1997 Apr; 86(4):514-6. PubMed ID: 9109058
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
Kurmi BD; Gajbhiye V; Kayat J; Jain NK
J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447
[TBL] [Abstract][Full Text] [Related]
13. The effect of malignant effusions on methotrexate disposition.
Li J; Gwilt P
Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595
[TBL] [Abstract][Full Text] [Related]
14. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
[TBL] [Abstract][Full Text] [Related]
15. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits.
Liang LS; Wong W; Burt HM
J Pharm Sci; 2005 Jun; 94(6):1204-15. PubMed ID: 15858840
[TBL] [Abstract][Full Text] [Related]
17. Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit.
Dukic S; Kaltenbach ML; Gourdier B; Marty H; Vistelle R
Pharm Res; 1998 Jan; 15(1):133-8. PubMed ID: 9487560
[TBL] [Abstract][Full Text] [Related]
18. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
19. Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin.
Chatterjee DJ; Li WY; Koda RT
Pharm Res; 1997 Aug; 14(8):1058-65. PubMed ID: 9279889
[TBL] [Abstract][Full Text] [Related]
20. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
